Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers
Clinical trial NCT04601844 · COMPLETED
Trial details
- NCT number
- NCT04601844
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2021-07-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.